Overview
XNCR market data
Price History
XNCR price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.24 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.84 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.92 – $21.76 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.5K · P/B 1.72 · P/S 15.20.
Company News
Wedbush Reiterates Outperform on Xencor, Maintains $26 Price TargetBenzinga · Jul 30, 2026, 1:38 PM
Xencor Announces $105M Settlement From Alexion Over US Ultomiris Royalties In Two $52.5M Payments; Ends US Royalties, Extends Operating Runway Through 2028Benzinga · Jul 29, 2026, 8:03 PM
AMC Entertainment, IREN, Hut 8 And Other Big Stocks Moving Higher On MondayBenzinga · Jul 20, 2026, 2:08 PM
Xencor shares are trading higher. The company announced that results from a Phase 1 study of XmAb819 in advanced clear cell renal cell carcinoma were accepted for a proffered paper oral presentation at the ESMO Congress 2026.Benzinga · Jul 17, 2026, 5:48 PM
Xencor Announces Phase 1 Study Results For XmAb819 Antibody Accepted For Proffered Paper Oral Presentation At European Society of Medical Oncology October 23-27Benzinga · Jul 17, 2026, 1:13 PM
Truist Securities Maintains Buy on Xencor, Lowers Price Target to $27Benzinga · Jul 7, 2026, 12:35 PM
8-K filing — Xencor Inc (XNCR)SEC EDGAR · May 6, 2026, 8:01 PM